In addition, estrogens could regulate other processes against AD, including spine density [54], long-term potentiation [55], neurotransmitter systems [56], protection against neuron cell death [57, 58], and tau hyperphosphorylation [48]. Here, MAPT is linked to Alzheimer disease.